Finding Mesothelioma Specialists

Finding mesothelioma doctors
 
In addition to our list of doctors and cancer centers known to have a special interest in mesothelioma, there are other ways to find doctors. A clinical trial search at the National Cancer Institute’s website http://www.cancer.gov/clinicaltrials lists the following 19 doctors and four pharmaceutical companies running clinical trials for mesothelioma. 
 
Because they are running trials they presumably have some interest or special knowledge of this particular type of cancer. Since trials are often opening and closing it is important to occasionally run a new search at the clinical trials website shown above. For a current listing of all mesothelioma clinical trials listed by the National Cancer Institute you can also see our page on mesothelioma clinical trials.  As of October 2007 there were 38 trials listed, 25 of those are in the United States.
 
Another way to find doctors is to run an Entrez PubMed search using the keyword mesothelioma. A list of article with their authors will be shown. Try to narrow it down by using additional keywords like pleural, and use limits to look at recent articles. Because these authors (doctors) are writing articles on mesothelioma they should have a better than average knowledge of it.
 

Doctors doing clinical trials on Mesothelioma with contact information
 
St. Vincent Medical Center - Los Angeles, California
Charles Wiseman, MD, FACP, Protocol chair Ph: 213-483-8464
 
 
Roswell Park Cancer Institute, Buffalo, New Yor
Todd Demmy, MD, Protocol chair Ph: 716-845-5873; 800-685-6825
 
 
Eastern Cooperative Oncology Group
Nasser Hanna, MD, Protocol chair Ph: 317-274-3515; 888-600-4822
 
 
Corey Langer, MD, Protocol co-chair Ph: 215-728-2985; 888-369-2427
Email: cj_langer@fccc.edu
North Central Cancer Treatment Group
Scott Okuno, MD, Protocol chair Ph: 507-284-2511
Email: okuno.scott@mayo.edu
 
 
Southwest Oncology Group
Linda Garland, MD, Protocol chair Ph: 520-626-3434; 800-622-2673
Email: lgarland@azcc.arizona.edu
Antoinette Wozniak, MD, Protocol co-chair Ph: 313-576-8752; 800-527-6266
Email: wozniakt@karmanos.org
 
 
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Massachusetts General Hospital Cancer Center, Boston, Massachusettes
University of Chicago Cancer Research Center
Joan Lucca, RN Ph: 617-632-5403
 
 
Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute
Geoffrey Shapiro, MD, PhD, Principal investigator Ph: 617-632-4942; 866-790-4500
Email: geoffrey_shapiro@dfci.harvard.edu
 
 
University of Chicago Cancer Research Center, Chicago, IL
Herbert Irving Comprehensive Cancer Center at Columbia University, NY, NY
Jonathan Dowell, MD Principal Investigator
Ph: 214-648-4180, Email: jonathan.dowell@utsouthwestern.edu
Erin Fenske Ph: 214-648-7097, Email: erin.fenske@utsouthwestern.edu
 
 
Case Comprehensive Cancer Center, Cleveland, Ohio
David Adelstein, MD, Protocol chair Ph: 216-444-9310
 
 
California Cancer Consortium
Suresh Ramalingam, MD, Protocol chair Ph: 412-648-6619
Email: ramalingams@upmc.edu
 
 
NCIC-Clinical Trials Group
Scott Laurie, MD, FRCPC, Protocol chair Ph: 613-533-6430
 
 
NCI - Center for Cancer Research
David Schrump, MD, Protocol chair Ph: 301-451-1233
Email: david_schrump@nih.gov
 
 
NCI - Center for Cancer Research
Raffit Hassan, MD, Principal investigator Ph: 301-451-8742
 
 
Memorial Sloan-Kettering Cancer Center, NY, NY
Lee Krug, MD, Principal investigator Ph: 212-639-8420; 800-525-2225
 
 
Abramson Cancer Center of the University of Pennsylvania
Biogen Idec, Incorporated
Daniel H. Sterman, M.D. Principal Investigator
Adri Recio, RN Ph: 215-573-6760
 
 
Merck and Company, Incorporated
Medical Monitor Study Director
Toll Free Number Ph:  1-888-577-8839
 
 
Bristol-Myers Squibb Company - New York
BMS Call Center Ph: 866-892-1BMS
 
 
Daiichi Pharmaceutical Corporation
Robert Gazak Ph: 919-465-4653
 

 

Alfacell Corporation 
Diane Scudiery, Protocol chair Ph: 973-748-8082

 

The information above is current as of October 2007